Carson Wealth (CWM LLC)
ATRS

Carson Wealth (CWM LLC)’s Antares Pharma, Inc. ATRS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-37,292
Closed -$153K – 4232
2022
Q1 		$153K Buy
37,292
+4,644
+14% +$16.8K ﹤0.01% 1159
2021
Q4 		$117K Buy
+32,648
New +$114K ﹤0.01% 1241
2021
Q2 		$146K Hold
33,550
– – ﹤0.01% 1005
2021
Q1 		$146K Hold
33,550
– – ﹤0.01% 1005
2020
Q4 		$146K Hold
33,550
– – ﹤0.01% 1005
2020
Q3 		$146K Hold
33,550
– – ﹤0.01% 1005
2020
Q2 		$146K Hold
33,550
– – ﹤0.01% 1005
2020
Q1 		$146K Hold
33,550
– – ﹤0.01% 1005
2019
Q4 		$146K Hold
33,550
– – ﹤0.01% 1005
2019
Q3 		$146K Hold
33,550
– – ﹤0.01% 1005
2019
Q2 		$146K Hold
33,550
– – ﹤0.01% 1005
2019
Q1 		$146K Buy
+33,550
New +$109K ﹤0.01% 1005

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ATRS Position: Q2 2022 in Review

Carson Wealth (CWM LLC) sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 37,292 shares — an estimated $153K sold.

Carson Wealth (CWM LLC) first reported a position in ATRS in Q1 2019 and held it in 12 quarters. The position peaked at $153K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Carson Wealth (CWM LLC) reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 37,292 Antares Pharma, Inc. shares in Q2 2022, an estimated $153K.
  • Carson Wealth (CWM LLC) first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 12 quarters.
  • Carson Wealth (CWM LLC)'s Antares Pharma, Inc. position peaked at $153K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2022, filed 28 Jul 2022.